Hypoxia in the heart, marked by insufficient oxygenation of cardiac tissue, disrupts cellular energetics, compromises ATP availability, and initiates a cascade of detrimental effects that undermine cardiac contractility and often maladaptive structural remodeling. Within the sarcomere, the fundamental contractile unit of muscle, ATP is critical for cross-bridge cycling between actin and myosin filaments, driving the force generation required for contraction. When ATP levels decline, the sarcomere’s efficiency in generating and sustaining force is compromised, exacerbating contractile dysfunction. While ATP's chemical energy is required for mechanical work, the binding of ATP to cross-bridges actually drives muscle relaxation as well, thus, reduced ATP levels also drive impaired relaxation kinetics observed in conditions such as rigor. Beyond metabolic stress, the immune response plays a critical role in cardiac adaptation to hypoxic injury, where resident and infiltrating macrophages dynamically modulate inflammatory and reparative processes. Although immune cells initially facilitate clearance of damaged cells and extracellular debris, their prolonged activation can contribute to maladaptive remodeling, further disrupting cardiac function and even leading to increased susceptibility to future hypoxic events. Despite extensive research, limitations persist in both sarcomere models, which struggle to fully capture metabolite-dependent dynamics, and in vitro and in vivo systems to study hypoxic cardiac injury, which often lack the complexity necessary to study cardiomyocyte-macrophage interactions in hypoxic contexts.
This dissertation addresses these gaps by advancing a novel spatially explicit, stochastic-mechanical sarcomere model that appropriately incorporates ATP, ADP, and inorganic phosphate concentrations within the kinetic framework of a cross-bridge cycle, enabling more accurate simulations of sarcomeric force production under varied metabolic conditions. Additionally, we present an innovative immuno-heart on a chip platform that recreates the hypoxic cardiac microenvironment in vitro, facilitating controlled studies of cardiomyocyte-macrophage reciprocal interactions and their impact on each cell type's function. The platform’s modular design allows precise modulation of macrophage phenotype and density, providing a robust system for probing the impacts of immune modulation on cardiac structure and contractility. Findings from this work reveal key insights into the energetic dependencies of sarcomere function and uncover the dual protective and detrimental roles macrophages play in cardiac contractility under hypoxia. Together, these contributions deepen our understanding of metabolic and immune influences on cardiac performance, offering a foundation for continued research and targeted therapies to mitigate hypoxia-induced cardiac dysfunction and improve recovery outcomes in ischemic heart disease.